DK175507B1 - N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater - Google Patents

N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK175507B1
DK175507B1 DK198803248A DK324888A DK175507B1 DK 175507 B1 DK175507 B1 DK 175507B1 DK 198803248 A DK198803248 A DK 198803248A DK 324888 A DK324888 A DK 324888A DK 175507 B1 DK175507 B1 DK 175507B1
Authority
DK
Denmark
Prior art keywords
alkyl
formula
group
acid
staurosporine
Prior art date
Application number
DK198803248A
Other languages
Danish (da)
English (en)
Other versions
DK324888A (da
DK324888D0 (da
Inventor
Giorgio Caravatti
Andreas Fredenhagen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK324888D0 publication Critical patent/DK324888D0/da
Publication of DK324888A publication Critical patent/DK324888A/da
Application granted granted Critical
Publication of DK175507B1 publication Critical patent/DK175507B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198803248A 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater DK175507B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH224487 1987-06-15
CH224487 1987-06-15
CH144088 1988-04-19
CH144088 1988-04-19

Publications (3)

Publication Number Publication Date
DK324888D0 DK324888D0 (da) 1988-06-14
DK324888A DK324888A (da) 1988-12-16
DK175507B1 true DK175507B1 (da) 2004-11-15

Family

ID=25687663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803248A DK175507B1 (da) 1987-06-15 1988-06-14 N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater

Country Status (20)

Country Link
EP (1) EP0296110B1 (sv)
JP (1) JP2708047B2 (sv)
KR (1) KR970001529B1 (sv)
AT (1) ATE134375T1 (sv)
AU (1) AU617324B2 (sv)
CA (1) CA1337763C (sv)
DE (1) DE3855015D1 (sv)
DK (1) DK175507B1 (sv)
ES (1) ES2083956T3 (sv)
FI (1) FI89362C (sv)
GR (1) GR3019064T3 (sv)
HK (1) HK1003788A1 (sv)
HU (1) HU201329B (sv)
IE (1) IE70523B1 (sv)
IL (1) IL86632A0 (sv)
MY (1) MY104316A (sv)
NO (1) NO170634C (sv)
NZ (1) NZ225018A (sv)
PT (1) PT87719B (sv)
YU (1) YU115488A (sv)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ucn―01
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
SK278989B6 (sk) * 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
USRE36736E (en) * 1989-02-06 2000-06-13 Hoffman-La Roche Inc. Substituted pyrroles
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
EP0540185A1 (en) * 1991-10-10 1993-05-05 Schering Corporation 4'-(N-substituted-N-oxide)staurosporine derivatives
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO1993018771A1 (fr) * 1992-03-24 1993-09-30 Asahi Kasei Kogyo Kabushiki Kaisha INHIBITEUR DE L'AGGLUTINATION PLAQUETTAIRE CONTENANT UN DERIVE DE STAUROSPORINE η-LACTAME
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
DE69331228D1 (en) * 1992-09-21 2002-01-10 Kyowa Hakko Kogyo Kk Heilmittel für thrombozytopenia
DE69435318D1 (de) 1993-01-28 2010-12-09 Boston Scient Ltd Therapeutische inhibitoren der zellen der glatten gefässmuskulatur
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
PH30300A (en) * 1993-05-07 1997-01-20 Ciba Geigy Ag Polycyclic compounds and processes for the preparation thereof
WO1995002057A1 (en) * 1993-07-09 1995-01-19 The Institute Of Cancer Research Protein tyrosine kinase and ligands thereof
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
JP2000514420A (ja) 1996-06-25 2000-10-31 セファロン・インコーポレイテッド 末梢または中枢神経障害およびサイトカイン過剰産生の治療のためのk―252a誘導体の使用
ATE278397T1 (de) 1997-03-31 2004-10-15 Boston Scient Ltd Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
ATE252387T1 (de) * 1998-11-23 2003-11-15 Novartis Pharma Gmbh Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen
PT2269603E (pt) 2001-02-19 2015-09-09 Novartis Ag Tratamento de tumores da mama com um derivado de rapamicina em combinação com exemestano
JP4477303B2 (ja) 2001-05-16 2010-06-09 ノバルティス アーゲー N−{5−[4−(4−メチル−ピペラジノ−メチル)−ベンゾイルアミド]−2−メチルフェニル}−4−(3−ピリジル)−2−ピリミジン−アミンおよび化学療法剤を含んでなる併用剤
KR20090087139A (ko) * 2001-10-30 2009-08-14 노파르티스 아게 Flt3 수용체 티로신 키나아제 활성의 억제제로서의 스타우로스포린 유도체
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
CN1652757B (zh) 2002-05-16 2012-02-08 诺瓦提斯公司 Edg受体结合剂在癌症中的应用
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
PE20050158A1 (es) 2003-05-19 2005-05-12 Irm Llc Compuestos inmunosupresores y composiciones
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
JP2007501774A (ja) 2003-08-08 2007-02-01 ノバルティス アクチエンゲゼルシャフト スタウロスポリンを含む組み合わせ
TW200538433A (en) 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
WO2006024494A1 (en) * 2004-08-31 2006-03-09 Novartis Ag Use of midostaurin for treating gastrointestinal stromal tumors
JO2897B1 (en) * 2004-11-05 2015-09-15 نوفارتيس ايه جي Organic compounds
SI2275103T1 (sl) 2005-11-21 2014-07-31 Novartis Ag mTor inhibitorji pri zdravljenju endokrinih tumorjev
PE20120336A1 (es) 2008-12-18 2012-04-30 Novartis Ag Sal de hemi-fumarato del acido 1-[4-[1-(4-ciclohexil-3-triflouro-metil-benciloxi-imino)-etil)-2-etil-bencil]-azetidin-3-carboxilico
AU2009335887A1 (en) 2008-12-18 2011-06-30 Novartis Ag New salts
BRPI0922457A2 (pt) 2008-12-18 2015-12-15 Novartis Ag forma polimórfica de ácido 1-(4-{1-[(e)-4-ciclo-hexil-3-trifluormetil-benziloxi-imino]-etil)-2-etil-benzil)-azetidino-3-carboxílico"
EP2327706A1 (en) 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013167403A1 (en) 2012-05-09 2013-11-14 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
US20220395553A1 (en) 2019-11-14 2022-12-15 Cohbar, Inc. Cxcr4 antagonist peptides
IT202000004291A1 (it) * 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN112812129A (zh) * 2020-12-31 2021-05-18 浙江海正药业股份有限公司 米哚妥林的新晶型及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
FI89362C (sv) 1993-09-27
HUT47587A (en) 1989-03-28
ATE134375T1 (de) 1996-03-15
EP0296110B1 (de) 1996-02-21
KR970001529B1 (ko) 1997-02-11
KR890000494A (ko) 1989-03-15
YU115488A (en) 1989-12-31
NO882613D0 (no) 1988-06-14
PT87719A (pt) 1988-07-01
NO170634C (no) 1992-11-11
IE70523B1 (en) 1996-12-11
IE881787L (en) 1988-12-15
GR3019064T3 (en) 1996-05-31
JPS6434989A (en) 1989-02-06
AU1757188A (en) 1988-12-15
ES2083956T3 (es) 1996-05-01
DK324888A (da) 1988-12-16
EP0296110A3 (de) 1991-02-27
PT87719B (pt) 1992-10-30
IL86632A0 (en) 1988-11-30
HU201329B (en) 1990-10-28
AU617324B2 (en) 1991-11-28
FI882808A0 (fi) 1988-06-13
DE3855015D1 (de) 1996-03-28
NZ225018A (en) 1990-09-26
EP0296110A2 (de) 1988-12-21
HK1003788A1 (en) 1998-11-06
MY104316A (en) 1994-03-31
CA1337763C (en) 1995-12-19
FI882808A (fi) 1988-12-16
NO170634B (no) 1992-08-03
NO882613L (no) 1988-12-16
JP2708047B2 (ja) 1998-02-04
DK324888D0 (da) 1988-06-14
FI89362B (fi) 1993-06-15

Similar Documents

Publication Publication Date Title
DK175507B1 (da) N-substituerede staurosporinderivater og salte deraf, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt anvendelse af de N-substituerede staurosporinderivater til fremstilling af farmaceutiske præparater
US5093330A (en) Staurosporine derivatives substituted at methylamino nitrogen
EP0148725B1 (en) Sulfonamido-benzamide derivatives
JP2010502617A (ja) 抗菌物質として有用なヒダントイン誘導体
US5962640A (en) Methods for preparing novel dipeptide compounds or pharmacuetically acceptable salts thereof
TW202321251A (zh) 新穎螺環吡咯啶衍生的抗病毒劑
ZA200409053B (en) (S)-4-Amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamin de, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor.
JP2019505532A (ja) Tlr7アゴニストのマレイン酸塩、その結晶形c、d及びe、マレイン酸塩及び結晶形の調製方法及び使用
WO2006101454A1 (en) Benzothiophene derivatives: preparation and pharmaceutical applications
RU2162470C2 (ru) 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения
NZ248737A (en) 5-oxo-dibenzo[a,d]cycohepta-1,4-dienes and medicaments thereof
EP1585757B1 (en) Peptide deformylase inhibitors
CN110117293B (zh) 多氟取代的Largazole类似物、其制备方法和用途
KR890002085B1 (ko) 디히드로오로트산 유도체의 제조방법
EP0812838B1 (en) Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
CA2122960A1 (en) Polycyclic compounds and processes for the preparation thereof
JP2006523612A (ja) ペプチドデホルミラーゼ阻害剤
WO1997005140A1 (en) Trindene compounds
WO2016107541A1 (zh) 吡咯酰胺类化合物及其制备方法与用途
WO2016107227A1 (zh) 吡咯酰胺类化合物及其制备方法与用途
IE852939L (en) Benzamide derivatives
NO328933B1 (no) Peptid-deformylaseinhibitorer
DD281808A5 (de) Verfahren zur herstellung n-substituierter derivate von staurosporin
CN117164524A (zh) 具有parp7/hdac双靶点抑制活性的哒嗪酮衍生物及其制备方法和应用
HRP940452A2 (en) Derivatives, substituted for the methylamino nitrogen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHS Application shelved for other reasons than non-payment
PUP Patent expired